6 Recruiting Chronic Kidney Disease Clinical Trials in California
Explore active chronic kidney disease research studies enrolling across California. Verify eligibility and contact site coordinators.
📍 Find Near Me by DistanceBrowse by City
Recruiting Chronic Kidney Disease Studies in California
🔵 Active, Not Recruiting Phase3 💊 Investigational Drug / Biologic
A Study to Learn More About How Well the Study Treatment Finerenone Works, How Safe it is, How it Moves Into, Through, and Out of the Body, and the Effects it Has on the Body When Taken With an ACE Inhibitor or Angiotensin Receptor Blocker in Children With Chronic Kidney Disease and Proteinuria
📍 Lucille Packard Children's Hospital Stanford - Pediatric Nephrology — Palo Alto, California
View Study & Checklist ➔ 🟡 Not Yet Recruiting Phase2 📋 Clinical Research Protocol
Nicotinamide Riboside Supplementation in Chronic Kidney Disease
📍 Altman Clinical and Translation Research Institute — San Diego, California
View Study & Checklist ➔ 🟢 Recruiting Phase2 💊 Investigational Drug / Biologic
A Research Study Comparing How Well Different Doses of the Medicine NNC0519-0130 Can Reduce Kidney Damage in People Living With Chronic Kidney Disease
📍 N America Res Inst - San Dimas — San Dimas, California
View Study & Checklist ➔ 🟢 Recruiting Phase1 💊 Investigational Drug / Biologic
Renal Impairment Study for Oral EC5026
📍 UC Davis Medical Center — Sacramento, California
View Study & Checklist ➔ 🟢 Recruiting Phase1 💊 Investigational Drug / Biologic
A Study to Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD4248 in Healthy Participants and Participants With Chronic Kidney Disease and Type 2 Diabetes and to Assess Home Measurements of Creatinine in a Non Interventional Cohort
📍 Research Site — Glendale, California
View Study & Checklist ➔ 🟢 Recruiting Phase3 💊 Investigational Drug / Biologic
A Study to Learn More About How Safe the Study Treatment Finerenone is in Long-term Use When Taken With an ACE Inhibitor or Angiotensin Receptor Blocker Over 18 Months of Use in Children and Young Adults From 1 to 18 Years of Age With Chronic Kidney Disease and Proteinuria
📍 Lucille Packard Children's Hospital Stanford - Pediatric Nephrology — Palo Alto, California
View Study & Checklist ➔